Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals

Eric Secemsky1, David Lange, David D Waters

  • 1Department of Internal Medicine at the University of California, San Francisco, CA, USA.

Insights

Cocaine use causes dangerous blood pressure spikes and arrhythmias in hypertensive patients. This highlights the severe cardiovascular risks for this vulnerable population.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension significantly increases risks for myocardial infarction, aortic dissection, and arrhythmias.
  • The specific hemodynamic and arrhythmogenic effects of cocaine use in hypertensive individuals remain poorly understood.

Purpose of the Study:

  • To investigate the transient changes in arterial pressures and the incidence of new arrhythmic activity during cocaine use in patients with hypertension.

Main Methods:

  • Ambulatory blood pressure, heart rate, and electrocardiograms (AECGs) were monitored for 48 hours in 10 hypertensive cocaine users.
  • Cocaine use was self-reported via diaries and cuff activation.
  • Eight of the 10 patients were on antihypertensive medications.

Main Results:

  • Cocaine use led to significant increases in systolic (74 mm Hg), diastolic (30 mm Hg), and mean arterial pressure (45 mm Hg) (P<.0001).
  • No significant change in heart rate was observed.
  • Arrhythmic activity increased, including atrial and ventricular ectopy, nonsustained atrial tachycardia, and nonsustained monomorphic ventricular tachycardia in some patients.

Conclusions:

  • Cocaine use induces extreme arterial pressure elevations in hypertensive patients, even those on medication.
  • Cocaine use is associated with increased arrhythmic activity in this population.
  • These findings may explain the elevated risk of severe cardiovascular events like myocardial infarction and aortic dissection in hypertensive cocaine users.

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as &#946;-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...